These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2950060)

  • 1. Assessment of immunomodulating activity of ofloxacin and three other quinolones in human plasma.
    De Simone C; Vullo V; Grassi M; Di Fabio S; Baldinelli L; Sorice F
    Infection; 1986; 14 Suppl 4():S248-9. PubMed ID: 2950060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphonuclear leucocyte chemotaxis little affected by three quinolones in vitro.
    Lombard JY; Descotes J; Evreux JC
    J Antimicrob Chemother; 1987 Oct; 20(4):614-5. PubMed ID: 3479421
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of ofloxacin, norfloxacin, nalidixic acid, pyromidic acid and pipemidic acid on human gamma-interferon production and blastogenesis.
    De Simone C; Baldinelli L; Ferrazzi M; De Santis S; Pugnaloni L; Sorice F
    J Antimicrob Chemother; 1986 Jun; 17(6):811-4. PubMed ID: 3090010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibiotics and chemotaxis in agarose. The role of incubation conditions and application to several fluoroquinolones].
    Descotes J; Lombard JY
    Pathol Biol (Paris); 1987 Dec; 35(10 Pt 2):1400-2. PubMed ID: 3325904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of quinolones on granulocyte function in vitro.
    Boogaerts MA; Malbrain S; Scheers W; Verwilghen RL
    Infection; 1986; 14 Suppl 4():S258-62. PubMed ID: 3469158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New synthetic quinolone antibacterial agents and serum concentration of theophylline.
    Niki Y; Soejima R; Kawane H; Sumi M; Umeki S
    Chest; 1987 Oct; 92(4):663-9. PubMed ID: 3477409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production].
    Guenounou M; Ronco E; Kodari E; Vacheron F; Momrikof V
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):785-9. PubMed ID: 3309816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Animal experiment studies on the modification of the immune system by ofloxacin].
    Pulverer G; Roszkowski W; Ko HL; Roszkowski K; Jeljaszewicz J
    Infection; 1986; 14 Suppl 1():S40-4. PubMed ID: 3456983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics of theophylline following two fluoroquinolones co-administration.
    Sano M; Yamamoto I; Ueda J; Yoshikawa E; Yamashina H; Goto M
    Eur J Clin Pharmacol; 1987; 32(4):431-2. PubMed ID: 3475207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the effect of ofloxacin and tanshinone II A on human leukocyte chemotactic migration in vitro].
    Zhou Z; Zheng J; Xu W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Jun; 19(3):232-5. PubMed ID: 10453497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of ofloxacin on murine Peyer's patch lymphocytes.
    De Simone C; Zanzoglu S; Santini G; Ciardi M; Delia S; Sorice F
    Infection; 1986; 14 Suppl 4():S256-7. PubMed ID: 3469157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT
    Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
    Obana Y; Nishino T
    Drugs Exp Clin Res; 1989; 15(2):53-8. PubMed ID: 2661182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of quinolones on human mononuclear leucocyte functions.
    Roche Y; Gougerot-Pocidalo MA; Fay M; Etienne D; Forest N; Pocidalo JJ
    J Antimicrob Chemother; 1987 Jun; 19(6):781-90. PubMed ID: 3497150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro comparative activity of norfloxacin in the comparison of pathogenic bacteria of the urinary tract].
    Carlone NA; Cuffini AM; Tullio V; Savoia D; Cavallo GP
    G Batteriol Virol Immunol; 1986; 79(1-6):85-97. PubMed ID: 3479370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between quinolones and caffeine.
    Staib AH; Stille W; Dietlein G; Shah PM; Harder S; Mieke S; Beer C
    Drugs; 1987; 34 Suppl 1():170-4. PubMed ID: 3481318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO; Izard D; Bryskier A; Leclerc H
    Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative activities in vitro of 4 quinolones (nalidixic acid, pefloxacin, norfloxacin, ofloxacin) on 13 bacterial species].
    Rahal K
    Arch Inst Pasteur Alger; 1992; 58():41-84. PubMed ID: 1309146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ofloxacin on the pharmacokinetics of a single intravenous theophylline dose.
    Al-Turk WA; Shaheen OM; Othman S; Khalaf RM; Awidi AS
    Ther Drug Monit; 1988; 10(2):160-3. PubMed ID: 3164150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.